Alternatives to PerkinElmer

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Global leader in life sciences, diagnostics, and applied chemical markets.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Develops advanced imaging solutions for life sciences research and diagnostics.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.